As the innovator and exclusive entity behind the 5-Hydroxyindoleacetic Acid Test Kit, Wuhan Chenkang Technology Co., Ltd. holds all rights to research and development, manufacturing, intellectual property, and process patents of the Screening Kit.
Tasked with the overarching management of international distribution, Hayman Health Limited is the primary company responsible for the supply chain of the Screening Kit.
"Uniting the world through better health" encapsulates our mission as we strive to be pioneers in global wellbeing. Committed to introducing superior health technologies to global communities, we are the international marketer and distributor of the Screening Kit.
Utilizing Hong Kong's prime position as a global city, we've established our global operations center to manage our sales and marketing efforts and to solidify the worldwide presence of our test kits.
We are actively turning Hong Kong into a hub for health technology, in collaboration with local healthcare institutions. Our goals are to ensure regulation-compliant quality supply, enhance public health awareness, and contribute to the wellbeing of Hong Kong and the world.
Our responsibilities extend to numerous aspects of product quality and distribution, including:
Anti-counterfeiting measures, such as labels and QR code tracking for each production batch
Adherence to local language requirements for instructions, packaging, and customer service
Conformance with production quality checks, manufacturing standards, and international packaging norms
Management of logistics and storage following strict protocols
Securing import permits/licenses from local regulatory bodies
Ensuring all exports and customs clearances are approved by respective local authorities
Overseeing regional sales and regulatory compliance globally
Handling product recalls and replacements when necessary
Providing local customer service and after-sales support
